Follow-up on short-course 2 months' rifampicin treatment of paucibacillary leprosy.
D003622:Dapsone / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D012293:Rifampin / Q000627:therapeutic use*
D003622:Dapsone; D012293:Rifampin